Aristotle University Of Thessaloniki (AUTH)
Συγκριτική κλινική και μορφολογική μελέτη χημικής πλευροδεσίας με ταλκ και υπερθερμία σε ασθενείς με καρκίνο του πνεύμονα και κακοήθη υπεζωκοτική συλλογή
Abstract
dc:descriptionThere is a plethora of treatment algorithms for managing patients with malignant pleural effusions (MPEs), sharing many common points and principles. The principal objective is fusion between the external surface of the pulmonary parenchyma (visceral pleura) and the inner surface of the thoracic cage (parietal pleura), effectively eliminating the pleural cavity and reaccumulation of pleural fluid. Our study aims to compare hyperthermic intrapleural chemotherapy (HITHOC) and talc pleurodesis (TALC), as treatment options for patients with non-small cell lung cancer (NSCLC) and metastatic MPE. This prospective, randomized trial was conducted at a single thoracic surgery center, the “Theagenio” Cancer Institute, in Greece, under the identification code NCT01409551 and was completed. All 40 patients enrolled were adults with histologically proven metastatic, unilateral, MPE caused by NSCLC. Exclusion criteria included patients >80 years, trapped lung, and major comorbidities. Patients were randomly and equally assigned 1:1 to either HITHOC (group A) or TALC (group B) by video assisted thoracic surgery (VATS). The primary outcome was the median overall survival (OS) from trial intervention to death, while secondary outcome was the identification of clinical factors affecting the survival. The patients were followed up for 45 months. The OS of the full group was 8 months (95% CI: 7.046–8.954). Participants who underwent HITHOC had an OS of 8 months (95% CI: 7.141–8.859), whereas the participants of TALC had an OS of 9 months (95% CI: 7.546–10.454), with no significant difference between groups. Among fifty-four factors that were tested for their effects on survival, only TNM stage and creatinine values both preoperatively and 7 days postoperatively could be regarded as risk-factors for survival. Other recorded parameters, which had significant variance between the two groups, were urea levels, C-reactive protein, white blood cells and total in hospital length of stay (LOS). Super microscopy of the pleural fluid did not reveal morphological differences at the cellular level between the groups. Both HITHOC and TALC are equally effective and safe therapeutic options in treating patients with MPE and NSCLC with acceptable survival. The study revealed independent clinical risk factors influencing survival, which could be utilized as starting points for larger clinical studies.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kleontas, Athanasios
- Κλέωντας, Αθανάσιος
Subjects
dc:subject × 19- Κακοήθης πλευριτική συλλογή
- Μη μικροκυτταρικός καρκίνος του πνεύμονα
- Πλευροδεσία
- Ενδοθωρακική υπερθερμική χημειοθεραπεία
- Χημική πλευροδεσία με ταλκ
- Malignant pleural effusion
- Non-small cell lung cancer
- Pleurodesis
- Intrathoracic hyperthermic chemoperfussion
- Talc pleurodesis
- Hyperthermic perfusion
- Intrapleural Perfusion with Hyperthermic
- Hyperthermic Intrapleural PErfusion Chemotherapy
- Hyperthermic IntraTHOracic Chemotherapy
- Hyperthermic Intrapleural chemotherapy
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45843